FibroGen, Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
17.60
|
|
Average Rating
|
3.14
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
5
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.81
|
-0.98
|
-0.17
|
-20.99%
|
|
2022-06-30
|
-0.94
|
-0.78
|
0.16
|
17.02%
|
|
2022-03-31
|
-0.83
|
-0.68
|
0.15
|
18.07%
|
|
2021-12-31
|
-0.66
|
-1.45
|
-0.79
|
-119.70%
|
|
2021-09-30
|
-0.01
|
0.54
|
0.55
|
5500.00%
|
|
2021-06-30
|
-0.48
|
-1.45
|
-0.97
|
-202.08%
|
|
2021-03-31
|
-0.87
|
-0.78
|
0.09
|
10.34%
|
|
2020-12-31
|
-0.24
|
-0.64
|
-0.40
|
-166.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.44
|
|
2021-12-31
|
-3.14
|
|
2020-12-31
|
-2.13
|
|
2019-12-31
|
-0.96
|
|
2018-12-31
|
-1.03
|
|
2017-12-31
|
-1.77
|
|
2016-12-31
|
-1.02
|
|
2015-12-31
|
-1.54
|
|
2014-12-31
|
-1.15
|